{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:52:30Z","timestamp":1787964750453,"version":"build-2784847793"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T00:00:00Z","timestamp":1574726400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T00:00:00Z","timestamp":1574726400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007279","name":"Shanghai Municipal Health Bureau","doi-asserted-by":"publisher","award":["2017YQ073"],"award-info":[{"award-number":["2017YQ073"]}],"id":[{"id":"10.13039\/501100007279","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004921","name":"Shanghai Jiao Tong University","doi-asserted-by":"publisher","award":["YG2016MS34"],"award-info":[{"award-number":["YG2016MS34"]}],"id":[{"id":"10.13039\/501100004921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81400723"],"award-info":[{"award-number":["81400723"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Primary nephrotic syndrome (PNS) is a common glomerular disease in children. T cell dysfunction plays a crucial role in the pathogenesis of PNS. Moreover, dysbiosis of gut microbiota contributes to immunological disorders. Whether the initial therapy of PNS affects gut microbiota remains an important question. Our study investigated compositional changes of gut microbiota after initial therapy.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Fecal samples of 20 children with PNS were collected before and after 4-week initial therapy. Total bacteria DNA were extracted and the V3-V4 regions of bacteria 16S ribosomal RNA gene were sequenced. The composition of gut microbiota before and after initial therapy was analyzed by bioinformatics methods. The function of altered gut microbiota was predicted with PICRUSt method.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>The richness and diversity of gut microbiota were similar before and after 4-week initial therapy. Gut microbiota at the phylum level was dominated by four phyla including <jats:italic>Firmicutes, Proteobacteria, Bacteroidetes<\/jats:italic> and <jats:italic>Actinobacteria<\/jats:italic>, but the increased relative abundance after initial therapy was found in <jats:italic>Deinococcus-Thermus<\/jats:italic> and <jats:italic>Acidobacteria<\/jats:italic>. At the genus level, the increased abundance of gut microbiota after initial therapy was observed in short chain fat acids (SCFA)-producing bacteria including <jats:italic>Romboutsia, Stomatobaculum<\/jats:italic> and <jats:italic>Cloacibacillus<\/jats:italic> (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). Moreover, the predicted functional profile of gut microbiota showed that selenocompound metabolism, isoflavonoid biosynthesis and phosphatidylinositol signaling system weakened after initial therapy of PNS.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Initial therapy of PNS increased SCFA-producing gut microbiota, but might diminish selenocompound metabolism, isoflavonoid biosynthesis and phosphatidylinositol signaling system in children.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12882-019-1615-4","type":"journal-article","created":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T08:03:02Z","timestamp":1574755382000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Compositional alterations of gut microbiota in children with primary nephrotic syndrome after initial therapy"],"prefix":"10.1186","volume":"20","author":[{"given":"Yulin","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen Ka-wai","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-hua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-yan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,26]]},"reference":[{"issue":"11","key":"1615_CR1","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1007\/s00467-009-1282-y","volume":"24","author":"N MacHardy","year":"2009","unstructured":"MacHardy N, Miles PV, Massengill SF, Smoyer WE, Mahan JD, Greenbaum L, Massie S, Yao L, Nagaraj S, Lin JJ, et al. Management patterns of childhood-onset nephrotic syndrome. Pediatr Nephrol. 2009;24(11):2193\u2013201.","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"1615_CR2","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3345\/kjp.2016.59.5.205","volume":"59","author":"SH Kim","year":"2016","unstructured":"Kim SH, Park SJ, Han KH, Kronbichler A, Saleem MA, Oh J, Lim BJ, Shin JI. Pathogenesis of minimal change nephrotic syndrome: an immunological concept. Korean J Pediatr. 2016;59(5):205\u201311.","journal-title":"Korean J Pediatr"},{"issue":"3","key":"1615_CR3","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.clim.2011.02.018","volume":"139","author":"LL Liu","year":"2011","unstructured":"Liu LL, Qin Y, Cai JF, Wang HY, Tao JL, Li H, Chen LM, Li MX, Li XM, Li XW. Th17\/Treg imbalance in adult patients with minimal change nephrotic syndrome. Clin Immunol. 2011;139(3):314\u201320.","journal-title":"Clin Immunol"},{"issue":"2","key":"1615_CR4","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/cei.12675","volume":"183","author":"R Bertelli","year":"2016","unstructured":"Bertelli R, Bonanni A, Di Donato A, Cioni M, Ravani P, Ghiggeri GM. Regulatory T cells and minimal change nephropathy: in the midst of a complex network. Clin Exp Immunol. 2016;183(2):166\u201374.","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"1615_CR5","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/ped.13255","volume":"59","author":"S Tsuji","year":"2017","unstructured":"Tsuji S, Kimata T, Yamanouchi S, Kitao T, Kino J, Suruda C, Kaneko K. Regulatory T cells and CTLA-4 in idiopathic nephrotic syndrome. Pediatr Int. 2017;59(5):643\u20136.","journal-title":"Pediatr Int"},{"issue":"2","key":"1615_CR6","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.cyto.2014.12.028","volume":"72","author":"N Prasad","year":"2015","unstructured":"Prasad N, Jaiswal AK, Agarwal V, Yadav B, Sharma RK, Rai M, Singh H, Chaturvedi S, Singh A. Differential alteration in peripheral T-regulatory and T-effector cells with change in P-glycoprotein expression in childhood Nephrotic syndrome: a longitudinal study. Cytokine. 2015;72(2):190\u20136.","journal-title":"Cytokine"},{"issue":"4","key":"1615_CR7","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1097\/BOR.0000000000000190","volume":"27","author":"RS Longman","year":"2015","unstructured":"Longman RS, Littman DR. The functional impact of the intestinal microbiome on mucosal immunity and systemic autoimmunity. Curr Opin Rheumatol. 2015;27(4):381\u20137.","journal-title":"Curr Opin Rheumatol"},{"issue":"7480","key":"1615_CR8","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature12721","volume":"504","author":"Y Furusawa","year":"2013","unstructured":"Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D, Nakanishi Y, Uetake C, Kato K, Kato T, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature. 2013;504(7480):446\u201350.","journal-title":"Nature"},{"issue":"3","key":"1615_CR9","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1159\/000487557","volume":"47","author":"S Tsuji","year":"2018","unstructured":"Tsuji S, Suruda C, Hashiyada M, Kimata T, Yamanouchi S, Kitao T, Kino J, Akane A, Kaneko K. Gut microbiota Dysbiosis in children with relapsing idiopathic Nephrotic syndrome. Am J Nephrol. 2018;47(3):164\u201370.","journal-title":"Am J Nephrol"},{"issue":"1","key":"1615_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jb\/mvw022","volume":"160","author":"T Yamada","year":"2016","unstructured":"Yamada T, Takahashi D, Hase K. The diet-microbiota-metabolite axis regulates the host physiology. J Biochem. 2016;160(1):1\u201310.","journal-title":"J Biochem"},{"key":"1615_CR11","doi-asserted-by":"publisher","unstructured":"Marker LM, Hammer AS, Andresen L, Isaack P, Clausen T, Byskov K, Honore OL, Jensen SK, Bahl MI. Short-term effect of oral amoxicillin treatment on the gut microbial community composition in farm mink (Neovison vison). FEMS Microbiol Ecol. 2017;93(7). https:\/\/doi.org\/10.1093\/femsec\/fix092.","DOI":"10.1093\/femsec\/fix092"},{"issue":"7402","key":"1615_CR12","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nature11053","volume":"486","author":"T Yatsunenko","year":"2012","unstructured":"Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M, Magris M, Hidalgo G, Baldassano RN, Anokhin AP, et al. Human gut microbiome viewed across age and geography. Nature. 2012;486(7402):222\u20137.","journal-title":"Nature"},{"issue":"9","key":"1615_CR13","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.it.2017.06.003","volume":"38","author":"A Kurilshikov","year":"2017","unstructured":"Kurilshikov A, Wijmenga C, Fu J, Zhernakova A. Host genetics and gut microbiome: challenges and perspectives. Trends Immunol. 2017;38(9):633\u201347.","journal-title":"Trends Immunol"},{"issue":"Suppl","key":"1615_CR14","first-page":"139","volume":"2","author":"Kidney Disease","year":"2012","unstructured":"Kidney Disease. Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. KDIGO Clinical Practice Guideline for Glomerulonephritis. KidneyIinter. 2012;2(Suppl):139\u2013274.","journal-title":"KidneyIinter"},{"issue":"12","key":"1615_CR15","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1007\/s004670100021","volume":"16","author":"PA McKinney","year":"2001","unstructured":"McKinney PA, Feltbower RG, Brocklebank JT, Fitzpatrick MM. Time trends and ethnic patterns of childhood nephrotic syndrome in Yorkshire, UK. Pediatr Nephrol. 2001;16(12):1040\u20134.","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"1615_CR16","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s00467-013-2720-4","volume":"29","author":"S Choudhary","year":"2014","unstructured":"Choudhary S, Agarwal I, Seshadri MS. Calcium and vitamin D for osteoprotection in children with new-onset nephrotic syndrome treated with steroids: a prospective, randomized, controlled, interventional study. Pediatr Nephrol. 2014;29(6):1025\u201332.","journal-title":"Pediatr Nephrol"},{"issue":"14","key":"1615_CR17","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.2217\/pgs.15.101","volume":"16","author":"E Cuzzoni","year":"2015","unstructured":"Cuzzoni E, De Iudicibus S, Franca R, Stocco G, Lucafo M, Pelin M, Favretto D, Pasini A, Montini G, Decorti G. Glucocorticoid pharmacogenetics in pediatric idiopathic nephrotic syndrome. Pharmacogenomics. 2015;16(14):1631\u201348.","journal-title":"Pharmacogenomics"},{"issue":"3","key":"1615_CR18","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1093\/ecco-jcc\/jjx153","volume":"12","author":"Y Wang","year":"2018","unstructured":"Wang Y, Gao X, Ghozlane A, Hu H, Li X, Xiao Y, Li D, Yu G, Zhang T. Characteristics of Faecal microbiota in Paediatric Crohn's Disease and their dynamic changes during infliximab therapy. J Crohns Colitis. 2018;12(3):337\u201346.","journal-title":"J Crohns Colitis"},{"issue":"1","key":"1615_CR19","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/1462-2920.13463","volume":"19","author":"A Riva","year":"2017","unstructured":"Riva A, Borgo F, Lassandro C, Verduci E, Morace G, Borghi E, Berry D. Pediatric obesity is associated with an altered gut microbiota and discordant shifts in Firmicutes populations. Environ Microbiol. 2017;19(1):95\u2013105.","journal-title":"Environ Microbiol"},{"issue":"5","key":"1615_CR20","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1007\/s00198-019-04855-5","volume":"30","author":"C Li","year":"2019","unstructured":"Li C, Huang Q, Yang R, Dai Y, Zeng Y, Tao L, Li X, Zeng J, Wang Q. Gut microbiota composition and bone mineral loss-epidemiologic evidence from individuals in Wuhan, China. Osteoporos Int. 2019;30(5):1003\u201313.","journal-title":"Osteoporos Int"},{"issue":"9","key":"1615_CR21","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/nbt.2676","volume":"31","author":"MG Langille","year":"2013","unstructured":"Langille MG, Zaneveld J, Caporaso JG, McDonald D, Knights D, Reyes JA, Clemente JC, Burkepile DE, Vega Thurber RL, Knight R, et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol. 2013;31(9):814\u201321.","journal-title":"Nat Biotechnol"},{"issue":"4","key":"1615_CR22","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s11684-019-0695-7","volume":"13","author":"H Zhang","year":"2019","unstructured":"Zhang H, Chang Y, Zheng Q, Zhang R, Hu C, Jia W. Altered intestinal microbiota associated with colorectal cancer. Front Med. 2019;13(4):461\u201370.","journal-title":"Front Med"},{"key":"1615_CR23","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3389\/fcimb.2012.00094","volume":"2","author":"F Guaraldi","year":"2012","unstructured":"Guaraldi F, Salvatori G. Effect of breast and formula feeding on gut microbiota shaping in newborns. Front Cell Infect Microbiol. 2012;2:94.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1\u20134","key":"1615_CR24","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1159\/000363209","volume":"127","author":"S Noel","year":"2014","unstructured":"Noel S, Martina-Lingua MN, Bandapalle S, Pluznick J, Hamad AR, Peterson DA, Rabb H. Intestinal microbiota-kidney cross talk in acute kidney injury and chronic kidney disease. Nephron Clinical practice. 2014;127(1\u20134):139\u201343.","journal-title":"Nephron Clinical practice"},{"issue":"9","key":"1615_CR25","doi-asserted-by":"publisher","first-page":"e107909","DOI":"10.1371\/journal.pone.0107909","volume":"9","author":"H Igarashi","year":"2014","unstructured":"Igarashi H, Maeda S, Ohno K, Horigome A, Odamaki T, Tsujimoto H. Effect of oral administration of metronidazole or prednisolone on fecal microbiota in dogs. PLoS One. 2014;9(9):e107909.","journal-title":"PLoS One"},{"key":"1615_CR26","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.lfs.2017.11.049","volume":"192","author":"T Wu","year":"2018","unstructured":"Wu T, Yang L, Jiang J, Ni Y, Zhu J, Zheng X, Wang Q, Lu X, Fu Z. Chronic glucocorticoid treatment induced circadian clock disorder leads to lipid metabolism and gut microbiota alterations in rats. Life Sci. 2018;192:173\u201382.","journal-title":"Life Sci"},{"issue":"1","key":"1615_CR27","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1097\/TP.0000000000001492","volume":"101","author":"J Tourret","year":"2017","unstructured":"Tourret J, Willing BP, Dion S, MacPherson J, Denamur E, Finlay BB. Immunosuppressive treatment alters secretion of Ileal antimicrobial peptides and gut microbiota, and favors subsequent colonization by Uropathogenic Escherichia coli. Transplantation. 2017;101(1):74\u201382.","journal-title":"Transplantation"},{"issue":"4","key":"1615_CR28","doi-asserted-by":"publisher","first-page":"171743","DOI":"10.1098\/rsos.171743","volume":"5","author":"JC Noguera","year":"2018","unstructured":"Noguera JC, Aira M, Perez-Losada M, Dominguez J, Velando A. Glucocorticoids modulate gastrointestinal microbiome in a wild bird. R Soc Open Sci. 2018;5(4):171743.","journal-title":"R Soc Open Sci"},{"issue":"2","key":"1615_CR29","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1210\/jc.2017-01983","volume":"103","author":"M Kanhere","year":"2018","unstructured":"Kanhere M, He J, Chassaing B, Ziegler TR, Alvarez JA, Ivie EA, Hao L, Hanfelt J, Gewirtz AT, Tangpricha V. Bolus weekly vitamin D3 supplementation impacts gut and airway microbiota in adults with cystic fibrosis: a double-blind, randomized, placebo-controlled clinical trial. J Clin Endocrinol Metab. 2018;103(2):564\u201374.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"1615_CR30","doi-asserted-by":"publisher","first-page":"e0166178","DOI":"10.1371\/journal.pone.0166178","volume":"11","author":"M Nadeem Aslam","year":"2016","unstructured":"Nadeem Aslam M, Bassis CM, Zhang L, Zaidi S, Varani J, Bergin IL. Calcium reduces liver injury in mice on a high-fat diet: alterations in microbial and bile acid profiles. PLoS One. 2016;11(11):e0166178.","journal-title":"PLoS One"},{"key":"1615_CR31","doi-asserted-by":"publisher","first-page":"e3698","DOI":"10.7717\/peerj.3698","volume":"5","author":"J Gerritsen","year":"2017","unstructured":"Gerritsen J, Hornung B, Renckens B, van Hijum S, VAP MDS, Rijkers GT, Schaap PJ, de Vos WM, Smidt H. Genomic and functional analysis of Romboutsia ilealis CRIB(T) reveals adaptation to the small intestine. PeerJ. 2017;5:e3698.","journal-title":"PeerJ"},{"key":"1615_CR32","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.nmni.2016.04.001","volume":"12","author":"D Ricaboni","year":"2016","unstructured":"Ricaboni D, Mailhe M, Khelaifia S, Raoult D, Million M. Romboutsia timonensis, a new species isolated from human gut. New Microbes New Infect. 2016;12:6\u20137.","journal-title":"New Microbes New Infect"},{"issue":"Pt 4","key":"1615_CR33","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1099\/ijs.0.042812-0","volume":"63","author":"MV Sizova","year":"2013","unstructured":"Sizova MV, Muller P, Panikov N, Mandalakis M, Hohmann T, Hazen A, Fowle W, Prozorov T, Bazylinski DA, Epstein SS. Stomatobaculum longum gen. Nov., sp. nov., an obligately anaerobic bacterium from the human oral cavity. Int J Syst Evol Microbiol. 2013;63(Pt 4):1450\u20136.","journal-title":"Int J Syst Evol Microbiol"},{"issue":"Pt 6","key":"1615_CR34","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1099\/ijs.0.044719-0","volume":"63","author":"T Looft","year":"2013","unstructured":"Looft T, Levine UY, Stanton TB. Cloacibacillus porcorum sp. nov., a mucin-degrading bacterium from the swine intestinal tract and emended description of the genus Cloacibacillus. Int J Syst Evol Microbiol. 2013;63(Pt 6):1960\u20136.","journal-title":"Int J Syst Evol Microbiol"},{"issue":"4","key":"1615_CR35","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.3390\/nu7042687","volume":"7","author":"F Hiller","year":"2015","unstructured":"Hiller F, Oldorff L, Besselt K, Kipp AP. Differential acute effects of selenomethionine and sodium selenite on the severity of colitis. Nutrients. 2015;7(4):2687\u2013706.","journal-title":"Nutrients"},{"issue":"1 Pt 2","key":"1615_CR36","first-page":"F56","volume":"263","author":"R Baliga","year":"1992","unstructured":"Baliga R, Baliga M, Shah SV. Effect of selenium-deficient diet in experimental glomerular disease. Am J Phys. 1992;263(1 Pt 2):F56\u201361.","journal-title":"Am J Phys"},{"issue":"10","key":"1615_CR37","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s00467-003-1237-7","volume":"18","author":"J Fydryk","year":"2003","unstructured":"Fydryk J, Olszewska M, Urasinski T, Brodkiewicz A. Serum selenium level and glutathione peroxidase activity in steroid-sensitive nephrotic syndrome. Pediatr Nephrol. 2003;18(10):1063\u20135.","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"1615_CR38","first-page":"483","volume":"34","author":"MH Javanbakht","year":"2014","unstructured":"Javanbakht MH, Sadria R, Djalali M, Derakhshanian H, Hosseinzadeh P, Zarei M, Azizi G, Sedaghat R, Mirshafiey A. Soy protein and genistein improves renal antioxidant status in experimental nephrotic syndrome. Nefrologia. 2014;34(4):483\u201390.","journal-title":"Nefrologia"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-019-1615-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-019-1615-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-019-1615-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T00:28:38Z","timestamp":1606264118000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-019-1615-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,26]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1615"],"URL":"https:\/\/doi.org\/10.1186\/s12882-019-1615-4","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,26]]},"assertion":[{"value":"22 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the ethical committee of Children\u2019s Hospital of Shanghai (#R037-F01). Written informed consent for participation in the study was obtained from patient\u2019s parents before the initial collection of stool samples.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"434"}}